Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancer

BACKGROUND: Previous studies showing an association between chronic use of proton pump inhibitor (PPI) and gastric cancer are limited by confounding by indication. This relationship has not been studied in patients receiving PPI for prophylaxis, such as those undergoing percutaneous coronary interve...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Andrew Kei-Yan, Ng, Pauline Yeung, Ip, April, Cheung, Ka-Shing, Siu, Chung-Wah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Gastric Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359470/
https://www.ncbi.nlm.nih.gov/pubmed/34380699
http://dx.doi.org/10.1136/bmjgast-2021-000719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359470/
https://www.ncbi.nlm.nih.gov/pubmed/34380699
http://dx.doi.org/10.1136/bmjgast-2021-000719

Ejemplares similares